Research Design and Behavioral Analysis - PowerPoint PPT Presentation

About This Presentation
Title:

Research Design and Behavioral Analysis

Description:

Placebo a pill or injection that has no medicinal value, but causes changes ... Identification of effective versus toxic dosages based upon body weight ... – PowerPoint PPT presentation

Number of Views:87
Avg rating:3.0/5.0
Slides: 27
Provided by: PeterM7
Learn more at: https://jan.ucc.nau.edu
Category:

less

Transcript and Presenter's Notes

Title: Research Design and Behavioral Analysis


1
Research Design and Behavioral Analysis
2
Research methods
  • Correlation Research used to determine if there
    is a relationship between two variables
  • Least amount of experimental control
  • Cannot be used to state cause and effect
    relationships

3
Research methods (cont.)
  • Experiment provides most confidence in
    determining cause and effect relationships.
    Manipulate the independent variable to see if
    changes occur in the dependent variable (measure)
  • Amphetamine study as an example

4
Research methods (cont)
  • Quasi-experiment similar to an experiment
    except the independent variable (IV) cannot be
    manipulated
  • IV is usually a subject variable
  • Subjects are assigned to groups for particular
    reason (gender, age, ethnic group, etc.)
  • Lack of random assignment reduces confidence in
    cause and effect statement
  • Modification of Amphetamine study as an example

5
Research methods (cont.)
  • The experimental design preferred in
    psychopharmacological research most control and
    confidence in cause and effect
  • Measures are usually behavioral changes that the
    drug was intended to cause and physical changes
    (side effects)
  • Side effects not always bad many drugs designed
    for one purpose, but later found to be useful for
    another because of unexpected actions

6
Experimental designs
  • All experiments begin with a control group and
    one or more experimental groups. The two
    principle experimental designs differ in how
    subjects are assigned to the groups

7
Within-subjects design
  • Only one group of subjects involved
  • All subjects receive all levels of treatment.
    They act as their own control and experimental
    group(s). Test before giving the drug
    baseline, then give the drug and measure any
    changes
  • Advantages
  • Need fewer subjects
  • You know groups are equal because they are the
    same subjects
  • Disadvantages
  • Carry over effects measuring independent
    variable to get baseline may change subjects in
    some way
  • Many times it requires more time delays between
    treatments

8
Between-subjects design
  • Different subjects are randomly assigned to
    different groups. Groups are assumed to be equal
    because each subject had an equal chance of being
    assigned to any group
  • Advantages
  • No carry-over effects
  • Quick
  • Disadvantages
  • More variability groups may not be equal by
    chance
  • More subjects required and you may not have many

9
Statistical analysis
  • Inferential statistics what is the probability
    that the difference between groups is the result
    of chance variations?
  • Within subjects design What is the probability
    that the difference in the baseline measure and
    the experimental trials was the result of chance?
  • Between groups What is the probability that the
    difference between the control group and
    experimental group(s) was due to chance?
  • Convention says to use probability of 1 or 5 out
    of 100 (Plt.01 or Plt.05)
  • With drug research using a P lt .01 is preferred

10
Validity
  • Internal validity How valid is our measurement?
    Are we measuring what we say we are measuring?
  • External validity How confident are we that we
    can generalize our results from our sample to a
    whole population? Is our sample truly
    representative of our population? Could it be
    biased?

11
Important issues with validity
  • 1. Within groups variability the average of the
    subjects in the experimental group performed
    differently than the average of the subjects in
    the control group, but perhaps a sub-group of the
    subjects did not show a difference in
    performance.
  • Example older subjects were very different, but
    younger subjects showed no change. Your study
    showed it worked for all subjects when it only
    affected older subjects

12
Important issues with validity (cont.)
  • 2. Use of a drug with a population not included
    in any of the samples used in the experiment.
  • Examples
  • 1. women excluded from testing hypertension
    drugs because of fluctuating hormones. These
    drugs used to treat hypertension in women.
  • 2. Prozac used to treat children when only
    tested on adults

13
Important issues with validity (cont.)
  • Placebo a pill or injection that has no
    medicinal value, but causes changes because of
    peoples expectations
  • Placebo effect if people given something that
    is suppose to help them, it may have an effect
    when in reality the drug had no effect. Has to
    be controlled by having the control group receive
    a placebo while experiment group receives
    experimental drug

14
Important issues with validity (cont.)
  • Hawthorne Effect people will sometimes improve
    because they get attention and feel that others
    are trying to help even if the drug they are
    given has no effect itself

15
Experimenter bias
  • A Person testing their drug has a strong desire
    for drug testing to be successful
  • They know what the desired effect is suppose to
    be
  • They may see the desired effect in the
    experimental group, and not see it in the control
    receiving the placebo because they know which
    group is which

16
Solution to experimenter bias
  • Use of multiple naïve observers who have no
    expectations about the which subjects should show
    a change
  • Use of double-blind techniques. Subjects are
    unaware if they are receiving the placebo or test
    drug (single-blind), and the experimenter is
    unaware of who was assigned to get the placebo
    and who is receiving the test drug.

17
Three group design
  • Most frequently used drug testing design
  • 1. experimental groups receives test drug
  • 2. control group 1 receives placebo
  • 3. control group 2 receives drug with known
    effects
  • Allows 3 different comparisons
  • 1. placebo to established drug was test
    sensitive enough to detect an effect
  • 2. placebo to experimental drug was there an
    effect
  • 3. established drug and experimental drug is
    new drug more effect or have fewer side effects

18
Dependent measures in psychopharmacological
research
  • Changes in observed behavior decrease in
    aggressive behaviors, decreased eating, etc.
  • Changes in human performance cognitive and
    motor tests
  • Self-report by subjects pain medication, on a
    scale of 1 to 10 with 1 being very little and 10
    being excruciating how do you rate your level of
    pain?

19
Dependent measures in psychopharmacological
research
  • Electroencephalogram (EEG)
  • Measure level of arousal of the cortex small
    fast waves indicate higher levels of arousal than
    large slow waves
  • Measure REM sleep deprivation of REM sleep has
    similar effect to total sleep deprivation. A
    side effect of some drugs is a disruption of REM
    sleep

20
Dependent measures in psychopharmacological
research
  • Perceptual measures
  • Sensory difference thresholds how different do
    two stimuli have to before you are able to detect
    a difference Does a drug make you more or less
    sensitive to these differences?
  • Critical frequency of fusion How fast does a
    light have to flicker on and off before you see
    it as a continuous light

21
Dependent measures in psychopharmacological
research (cont.)
  • Cognitive tests
  • Motor tests sobriety test
  • Combination driving tests

22
Measuring performance in nonhumans
  • Drug effects on the performance on operant
    conditioning and different schedules of
    reinforcement
  • Avoidance escape tasks animals learn to avoid
    an unpleasant stimuli or they learn to escape an
    unpleasant stimuli they cant avoid
  • Anxiety reducing drugs decrease avoidance
    behavior but not escape behavior

23
Measuring performance in nonhumans
  • Use of punishment anything that decreases
    magnitude or frequency of a behavior. Does the
    drug decrease the effectiveness of punishment.
    Sedatives do amphetamines do not
  • Drug discrimination paradigm teach animal to
    discriminate between the effects of a placebo and
    the effects of a particular drug
  • Used to determine if a new drug has a similar
    effect as an older drug
  • Also if the two drugs have the same effect on the
    actions of neurotransmitters

24
Drug development and testing
  • Major issue with psychoactive drugs
  • 1. we know most mental disorders involve
    biochemical imbalances
  • 2. we know that psychoactive drugs operate on
    the effect of neurotransmitter systems
  • 3. we do not know exactly what the specific
    biochemical imbalance is in most disorders so it
    is difficult to know what drug will work with
    what disorder
  • This results in extensive testing with nonhumans
  • This results in extensive testing with nonhumans

25
Nonhuman testing
  • Purpose
  • Identification of exactly which neurotransmitter
    system or systems the drug effects and identifies
    possible side effects
  • Identification of effective versus toxic dosages
    based upon body weight looking for drugs with
    the largest difference between the two
  • Obviously interspecies differences a problem

26
Human testing
  • Purpose
  • Identify short-term and long-term effects in
    humans
  • Detailed analysis of aversive effects never
    ending unless drug is discontinued
Write a Comment
User Comments (0)
About PowerShow.com